Increased antibiotic duration improves survival of irrigation and debridement after revision total joint arthroplasty.
Hip
Infection
Irrigation and debridement
Knee
Total joint arthroplasty
Journal
Journal of orthopaedics
ISSN: 0972-978X
Titre abrégé: J Orthop
Pays: India
ID NLM: 101233220
Informations de publication
Date de publication:
Historique:
received:
19
08
2019
accepted:
14
11
2019
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
7
2
2020
Statut:
epublish
Résumé
We sought to evaluate reoperation-free survival following I&D with modular component exchange of revision total joint arthroplasty (TJA). Of revision TJAs from 2004 to 2012 (n = 4,166), 30 were I&D with modular component exchange after index revision for aseptic indications. Patients with (n = 12) and without (n = 18) reoperation for infection recurrence were analyzed. Reoperation-free survival (60% at mean 4.8 year follow-up) improved with increased duration of antibiotic therapy (p = 0.0185), with maximum benefit at 2 years. At least 2 years of antibiotic therapy should be administered after I&D with modular component exchange for acutely infected revision TJA. Level III, retrospective comparative study.
Sections du résumé
BACKGROUND
BACKGROUND
We sought to evaluate reoperation-free survival following I&D with modular component exchange of revision total joint arthroplasty (TJA).
METHODS
METHODS
Of revision TJAs from 2004 to 2012 (n = 4,166), 30 were I&D with modular component exchange after index revision for aseptic indications. Patients with (n = 12) and without (n = 18) reoperation for infection recurrence were analyzed.
RESULTS
RESULTS
Reoperation-free survival (60% at mean 4.8 year follow-up) improved with increased duration of antibiotic therapy (p = 0.0185), with maximum benefit at 2 years.
CONCLUSIONS
CONCLUSIONS
At least 2 years of antibiotic therapy should be administered after I&D with modular component exchange for acutely infected revision TJA.
LEVEL OF EVIDENCE
METHODS
Level III, retrospective comparative study.
Identifiants
pubmed: 32025113
doi: 10.1016/j.jor.2019.11.020
pii: S0972-978X(19)30589-6
pmc: PMC6997659
doi:
Types de publication
Journal Article
Langues
eng
Pagination
84-88Informations de copyright
© 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
On behalf of all authors, the corresponding author declares that there are no conflicts of interest.
Références
J Arthroplasty. 2009 Sep;24(6 Suppl):101-4
pubmed: 19553077
Clin Microbiol Infect. 2014 Nov;20(11):O911-9
pubmed: 24766536
Antimicrob Agents Chemother. 2009 Nov;53(11):4772-7
pubmed: 19687237
Knee. 2018 Oct;25(5):932-938
pubmed: 30111501
J Arthroplasty. 2014 Mar;29(3):469-72
pubmed: 23998990
J Orthop. 2018 May 07;15(2):707-710
pubmed: 29881225
J Bone Joint Surg Am. 2003 Jan;85(1):27-32
pubmed: 12533568
J Bone Joint Surg Am. 2014 Apr 16;96(8):624-30
pubmed: 24740658
J Arthroplasty. 2017 Apr;32(4):1280-1284
pubmed: 27876465
J Arthroplasty. 2012 Jun;27(6):857-64.e1-4
pubmed: 22402229
Clin Orthop Relat Res. 1991 Dec;(273):113-8
pubmed: 1959257
J Arthroplasty. 2011 Sep;26(6 Suppl):114-8
pubmed: 21621955
Clin Orthop Relat Res. 2011 Nov;469(11):2992-4
pubmed: 21938532
Clin Orthop Relat Res. 2011 Apr;469(4):970-6
pubmed: 20544317
Clin Orthop Relat Res. 2015 Jun;473(6):2131-8
pubmed: 25467789
Clin Infect Dis. 2006 Feb 15;42(4):471-8
pubmed: 16421790
J Arthroplasty. 2015 Sep;30(9):1623-8
pubmed: 25935234
Clin Infect Dis. 2007 Nov 1;45(9):1113-9
pubmed: 17918072
Clin Orthop Relat Res. 2014 Jul;472(7):2197-200
pubmed: 24615421
Clin Orthop Relat Res. 2013 Jan;471(1):250-7
pubmed: 22552768